Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 13/20 | 0.67 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.56 |
| ▸ | CACNA1G | O43497 | 6/20 | 0.45 |
| ▸ | CACNA1H | O95180 | 6/20 | 0.45 |
| ▸ | CACNA1I | Q9P0X4 | 6/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4687482 | 0.93 | S1PR1 (0.69) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4687175 | 0.93 | S1PR1 (0.77) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4687478 | 0.92 | S1PR1 (0.79) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4688979 | 0.91 | S1PR1 (0.64) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4684850 | 0.91 | S1PR1 (0.70) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4687836 | 0.91 | S1PR1 (0.73) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4689619 | 0.90 | S1PR1 (0.67) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4688963 | 0.90 | S1PR1 (0.67) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4687731 | 0.89 | S1PR1 (0.63) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I | |
| SCHEMBL4689384 | 0.89 | S1PR1 (0.62) | S1PR1S1PR3CACNA1GCACNA1HCACNA1I |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1805163-B1 | 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2008-10-01 | — | — | EP | claimed |